ANTISENSE MODULATION OF MDM2 EXPRESSION

Details for Australian Patent Application No. 2002364125 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors CHIANG, Ming, Yi; MANOHARAN, Muthiah; MIRAGLIA, Loren, J.; NERO, Pamela, S.; GRAHAM, Mark, J.; MONIA, Brett, P.; KOLLER, Erich

Pub. Number AU-A-2002364125

PCT Number PCT/US02/38281

PCT Pub. Number WO2003/048315

Priority 10/005,344 04.12.01 US

Filing date 2 December 2002

Wipo publication date 17 June 2003

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 10/005,344 04.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002364125

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364126-COMPOSITE FLUID DISTRIBUTION AND FLUID RETENTION LAYER HAVING MACHINE DIRECTION ZONES AND Z-DIRECTION GRADIENTS FOR PERSONAL CARE PRODUCTS

2002364124-METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS